CK Life Sciences International (Holdings), Inc. (0775) Financial Statements

4 Followers

CK Life Sciences International (Holdings), Inc. Financial Overview

CK Life Sciences International (Holdings), Inc.'s market cap is currently HK$6.92B. The company's EPS TTM is HK$-0.004; its P/E ratio is -41.82; CK Life Sciences International (Holdings), Inc. is scheduled to report earnings on March 17, 2026, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	HK$ 5.41B	HK$ 5.52B	HK$ 5.32B	HK$ 5.28B	HK$ 5.40B
Gross Profit	HK$ 785.38M	HK$ 1.69B	HK$ 1.64B	HK$ 1.63B	HK$ 1.63B
Operating Income	HK$ -135.28M	HK$ 783.06M	HK$ 223.85M	HK$ 219.51M	HK$ 233.69M
EBITDA	HK$ -49.42M	HK$ 337.27M	HK$ 624.75M	HK$ 469.51M	HK$ 449.14M
Net Income	HK$ -188.45M	HK$ -126.55M	HK$ 17.25M	HK$ 131.96M	HK$ 162.80M
Balance Sheet
Cash & Short-Term Investments	HK$ 603.07M	HK$ 571.21M	HK$ 676.16M	HK$ 704.13M	HK$ 902.47M
Total Assets	HK$ 11.84B	HK$ 10.79B	HK$ 11.25B	HK$ 11.27B	HK$ 11.73B
Total Debt	HK$ 6.62B	HK$ 6.10B	HK$ 5.93B	HK$ 5.95B	HK$ 6.21B
Net Debt	HK$ 6.02B	HK$ 5.55B	HK$ 5.27B	HK$ 5.25B	HK$ 5.32B
Total Liabilities	HK$ 7.99B	HK$ 7.28B	HK$ 7.06B	HK$ 7.11B	HK$ 7.23B
Stockholders' Equity	HK$ 3.78B	HK$ 3.51B	HK$ 4.19B	HK$ 4.16B	HK$ 4.50B
Cash Flow
Free Cash Flow	HK$ -277.76M	HK$ 157.00M	HK$ 222.35M	HK$ 146.69M	HK$ 206.33M
Operating Cash Flow	HK$ -32.77M	HK$ 353.53M	HK$ 514.18M	HK$ 363.66M	HK$ 423.57M
Investing Cash Flow	HK$ -362.68M	HK$ -96.64M	HK$ -67.96M	HK$ -22.12M	HK$ -257.88M
Financing Cash Flow	HK$ 428.57M	HK$ -341.98M	HK$ -477.95M	HK$ -515.34M	HK$ -220.08M

Currency in HKD

CK Life Sciences International (Holdings), Inc. Earnings and Revenue History

Income Statement >

CK Life Sciences International (Holdings), Inc. Debt to Assets

Balance Sheet >

CK Life Sciences International (Holdings), Inc. Cash Flow

Cash Flow >

CK Life Sciences International (Holdings), Inc. Forecast EPS vs Actual EPS

Earnings >